Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Proof-of-concept study of NPS-1776 in migraine fails to meet primary endpoint

Oct. 15, 2004

Launches and court orders for generic gabapentin

Oct. 15, 2004

Enrollment completed in adult insomnia phase II study of SO-101

Oct. 15, 2004

New analgesic agents identified by Italian researchers

Oct. 15, 2004

New Nurr1 activators with potential utility in PD therapy

Oct. 13, 2004

New monoamine reuptake inhibitors developed at NeuroSearch

Oct. 13, 2004

Prous Science announces publication of a comprehensive review on sleep apnea

Oct. 13, 2004

Santhera grants Genzyme license for discovery of therapies for muscular diseases

Oct. 11, 2004

New 5-HT1A ligands/5-HT reuptake inhibitors covered by Merck KGaA patent

Oct. 11, 2004

Novel NMDA GlyB-site antagonists discovered at Gruenenthal

Oct. 11, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...